Detalles de la búsqueda
1.
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Blood
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805638
2.
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.
Br J Haematol
; 200(2): 170-174, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263593
3.
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry.
Ann Hematol
; 102(10): 2815-2822, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474632
4.
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.
Invest New Drugs
; 40(2): 438-452, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34837603
5.
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.
Blood
; 134(12): 951-959, 2019 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292112
6.
Toll-like receptor gene polymorphisms in patients with myeloproliferative neoplasms.
Mol Biol Rep
; 48(6): 4995-5001, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34191235
7.
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
Int J Cancer
; 142(5): 883-890, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29023692
8.
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.
Hematol Oncol
; 36(1): 189-195, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28643458
9.
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Blood
; 126(20): 2302-6, 2015 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429976
10.
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.
Blood Cells Mol Dis
; 57: 54-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26852656
11.
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.
Blood
; 121(11): 1935-43, 2013 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23319575
12.
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.
Cancer Invest
; 2015 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26279306
13.
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
Cancer Invest
; 33(9): 451-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26288116
14.
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
Ann Hematol
; 94(8): 1347-56, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25975975
15.
Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI-PIO) in chronic myeloid leukemia with deep molecular response.
Am J Hematol
; 95(12): E321-E323, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32864746
16.
BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution.
Acta Haematol
; 134(4): 248-54, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26159458
17.
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.
Br J Haematol
; 166(4): 540-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24796963
18.
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Ann Hematol
; 93(12): 2001-10, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24981688
19.
Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study.
Front Oncol
; 14: 1393191, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38779092
20.
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.
Blood Adv
; 8(10): 2361-2372, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447114